Skip to main content

Alimera Sciences Inc

ALIMDelisted Sep 16, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001267602

Alimera Sciences Inc was delisted on Sep 16, 2024; its insiders filed their last Form 4 on Sep 18, 2024; 52 institutions reported holding it in 13F filings for Q2 2024, worth $257.9M in total; no superinvestor held it.

Q1 2024 vs. Q4 2023

How the institutions holding Alimera Sciences Inc changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of ALIM: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders3539+4
Shares48.2M47.9M−327.0K (−0.7%)
Value$208.4M$186.9M−$21.5M (−10.3%)

New holders (10)

Institutions that held Alimera Sciences Inc at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to ALIM in Q1 2024
InstitutionSharesValue% of portfolio
Ancora Advisors, LLC234,620$915.0K0.02%
State Street Corp133,016$518.8K0.00%
Marshall Wace, LLP85,301$332.7K0.00%
Goldman Sachs Group Inc71,758$279.9K0.00%
Qube Research & Technologies Ltd46,678$182.0K0.00%
Hillsdale Investment Management Inc.43,400$169.3K0.01%
HRT Financial LP25,586$99.0K0.00%
Fifth Lane Capital, LP21,238$82.8K0.11%
Steward Partners Investment Advisory, LLC666$2.60K0.00%
Macquarie Group Ltd523$20.00%

Sold out (6)

Institutions that held Alimera Sciences Inc at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of ALIM in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Worth Venture Partners, LLC556,642$2.40M
HighTower Advisors, LLC25,091$108.0K
ExodusPoint Capital Management, LP19,376$84.0K
Acadian Asset Management LLC5,263$22.0K
Focused Wealth Management, Inc66$285
UBS Group AG2$9